Slowly but surely: how to reduce hepatitis C prevalence
Modest increases in hepatitis C treatment rates amongst people who inject drugs will significantly reduce infection prevalence, resulting in benefits for both individuals and the public.
Download report![Square Margaret Hellard 210X210](/media/1c2jothb/square_margaret_hellard_210x210.jpeg?quality=100)
Professor Margaret Hellard AM
For almost two decades Margaret’s work has centred around infectious diseases, preventing their transmission and identifying the impact of these infections in vulnerable populations. A researcher and clinician, her principal research interests are in the epidemiology of blood-borne viruses (BBVs) HIV, hepatitis B and hepatitis C, sexually transmitted infections, and improving the management of individuals who already have the infection.
EMAIL